RS64986B1 - Modulatori receptora alfa (err-alfa) povezanog sa estrogenom - Google Patents

Modulatori receptora alfa (err-alfa) povezanog sa estrogenom

Info

Publication number
RS64986B1
RS64986B1 RS20231236A RSP20231236A RS64986B1 RS 64986 B1 RS64986 B1 RS 64986B1 RS 20231236 A RS20231236 A RS 20231236A RS P20231236 A RSP20231236 A RS P20231236A RS 64986 B1 RS64986 B1 RS 64986B1
Authority
RS
Serbia
Prior art keywords
alpha
err
estrogen
modulators
related receptor
Prior art date
Application number
RS20231236A
Other languages
English (en)
Inventor
Jaap Gerardus Henricus Lemmers
Eugen Deretey
Johannes Petrus Gerardus Klomp
Joseph Maria Gerardus Cals
Arthur Oubrie
Original Assignee
Lead Pharma Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Pharma Holding Bv filed Critical Lead Pharma Holding Bv
Publication of RS64986B1 publication Critical patent/RS64986B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20231236A 2019-10-18 2020-10-16 Modulatori receptora alfa (err-alfa) povezanog sa estrogenom RS64986B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19204189 2019-10-18
EP20792415.0A EP4045503B1 (en) 2019-10-18 2020-10-16 Estrogen-related receptor alpha (err-alpha) modulators
PCT/EP2020/079166 WO2021074365A1 (en) 2019-10-18 2020-10-16 ESTROGEN-RELATED RECEPTOR ALPHA (ERRα) MODULATORS

Publications (1)

Publication Number Publication Date
RS64986B1 true RS64986B1 (sr) 2024-01-31

Family

ID=68296174

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20231236A RS64986B1 (sr) 2019-10-18 2020-10-16 Modulatori receptora alfa (err-alfa) povezanog sa estrogenom

Country Status (18)

Country Link
US (1) US20240150342A1 (sr)
EP (1) EP4045503B1 (sr)
JP (1) JP2023501081A (sr)
KR (1) KR20220084355A (sr)
CN (1) CN114630827A (sr)
AU (1) AU2020365434A1 (sr)
BR (1) BR112022006906A2 (sr)
CA (1) CA3151045A1 (sr)
CO (1) CO2022003829A2 (sr)
ES (1) ES2970386T3 (sr)
HR (1) HRP20240237T1 (sr)
IL (1) IL291523B2 (sr)
MA (1) MA57379B1 (sr)
MX (1) MX2022004394A (sr)
PL (1) PL4045503T3 (sr)
RS (1) RS64986B1 (sr)
WO (1) WO2021074365A1 (sr)
ZA (1) ZA202203025B (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202315620A (zh) * 2021-08-03 2023-04-16 英屬開曼群島商百濟神州有限公司 吡唑并吡啶酮化合物
WO2023165525A1 (en) * 2022-03-01 2023-09-07 Insilico Medicine Ip Limited Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ579372A (en) * 2007-03-07 2012-02-24 Janssen Pharmaceutica Nv Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
EP2464647B1 (en) * 2009-08-11 2016-09-21 Bristol-Myers Squibb Company Azaindazoles as btk kinase modulators and use thereof
EP2970264A1 (en) * 2013-03-14 2016-01-20 AbbVie Inc. Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors

Also Published As

Publication number Publication date
CA3151045A1 (en) 2021-04-22
WO2021074365A1 (en) 2021-04-22
MA57379B1 (fr) 2024-02-29
MX2022004394A (es) 2022-05-18
CO2022003829A2 (es) 2022-07-08
EP4045503A1 (en) 2022-08-24
HRP20240237T1 (hr) 2024-05-10
PL4045503T3 (pl) 2024-05-06
EP4045503C0 (en) 2023-12-06
US20240150342A1 (en) 2024-05-09
IL291523B1 (en) 2023-08-01
IL291523B2 (en) 2023-12-01
ES2970386T3 (es) 2024-05-28
EP4045503B1 (en) 2023-12-06
JP2023501081A (ja) 2023-01-18
CN114630827A (zh) 2022-06-14
KR20220084355A (ko) 2022-06-21
AU2020365434A1 (en) 2022-05-26
BR112022006906A2 (pt) 2022-07-05
IL291523A (en) 2022-05-01
ZA202203025B (en) 2023-12-20

Similar Documents

Publication Publication Date Title
EP4069686A4 (en) GLP-1 RECEPTOR AGONIST
FI3953327T3 (fi) Melanokortiini-4-reseptoriagonisteja
SG11202105256QA (en) Novel compounds having estrogen receptor alpha degradation activity and uses thereof
IL276295A (en) Modulators of chemokine receptors and their uses
IL268319A (en) Benzothiophene estrogen receptor modulators
IL291523A (en) Estrogen-related alpha receptor modulators (erraalpha)
IL276332A (en) Spiro-lactam NMDA receptor modulators and their use
IL276330A (en) Spiro-lactam NMDA receptor modulators and their use
IL289510A (en) Estrogen-related receptor modulators (erralpha)
IL286461A (en) Estrogen receptor breaks down protacs
IL268263A (en) Estrogen receptor modulators
EP3565543A4 (en) MU TYPE OPIOID RECEIVER MODULATORS
EP4000022A4 (en) ORGANIZATIONAL FRAMEWORK FOR NON-FUNCTIONAL REQUIREMENTS
GB201911187D0 (en) Receptor
ZA202201157B (en) Selective estrogen receptor degrader
EP3581572B8 (en) Adenosine a3 receptor modulators
IL289575A (en) nmda receptor modulators
EP3927330A4 (en) NURR1 RECEPTOR MODULATORS
EP3904374A4 (en) OBJECT MODIFIED BY A T LYMPHOCYTE RECEPTOR
EP4043484A4 (en) SOMATOSTATIN RECEPTOR
GB201801595D0 (en) Reaction Modulators